TCW GROUP INC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCW GROUP INC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$1,699,000
+76.6%
19,978
-26.4%
0.02%
+72.7%
Q2 2020$962,000
+60.6%
27,138
-38.9%
0.01%
+37.5%
Q1 2020$599,000
-1.0%
44,404
+55.4%
0.01%
+14.3%
Q4 2019$605,000
+58.0%
28,575
-0.9%
0.01%
+75.0%
Q3 2019$383,00028,8490.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders